FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to the field of pharmaceutics. An extract of Fraxinus excelsior seeds, capable of activating PPAR-alpha, which contains nuzhenide GI3, oleoside methyl ester, excelside B, GI5, salidroside, in effective quantities. An application of the extract of Fraxinus excelsior seeds to obtain a medication for treating a state, in which the PPAR-alpha activation is useful, is described. Also described is a method of treating a subject with the state, in which the PPAR-alpha activation is useful. A method of obtaining the extract of Fraxinus excelsior seeds is disclosed.
EFFECT: application of the claimed extract makes it possible to treat states, in which the PPAR-alpha activation is useful in an efficient way.
14 cl, 11 dwg, 2 tbl, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW APPLICATIONS AND METHODS | 2017 |
|
RU2765804C2 |
| CONJUGATED LIPID DERIVATIVES | 2007 |
|
RU2480447C2 |
| ENANTIOMER OF SUBSTITUTED PHENYLPROPIONIC ACID AND A METHOD FOR PRODUCTION THEREOF, COMPOSITION THEREOF AND USE THEREOF | 2017 |
|
RU2735524C2 |
| ROR-GAMMA MODULATORS | 2012 |
|
RU2658013C2 |
| SPIROCHROMANONE DERIVATIVES AS ACETYL COENZYME A CARBOXYLASE (ACC) INHIBITORS | 2006 |
|
RU2422446C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF DIABETES AND RELATED METABOLIC DISEASES | 2021 |
|
RU2809286C1 |
| PHARMACEUTICAL COMBINATION CONTAINING SGLT2 INHIBITOR | 2008 |
|
RU2489151C2 |
| ANTIDIABETIC OXAZOLIDINEDIONES | 2005 |
|
RU2355682C2 |
| NUCLEAR RECEPTOR BINDING AGENTS | 2011 |
|
RU2604666C2 |
| DERIVATIVE COMPOUNDS OF CARBOXYLIC ACID AND AGENTS COMPRISING THEREOF AS ACTIVE COMPONENTS | 2002 |
|
RU2296760C2 |
